These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19334634)

  • 41. [Antiarrhythmic activity of alaglyzin].
    Bryzgalov AO; Volkova EB; Ganenko IuA; Dolgikh MP; Zhukova NA; Sorokina IV; Tolstikova TG
    Eksp Klin Farmakol; 2005; 68(4):24-7. PubMed ID: 16193652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Absorption of fatty acids by the rat heart in arrhythmia].
    Bogdarin IuA; Kozin VV; Men'kova IE; Shirokova NIu
    Patol Fiziol Eksp Ter; 2008; (4):14-6. PubMed ID: 19198266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the antiarrhythmic and circulatory actions of lidocaine (Xylocaine).
    Harrison DC; Gianelly RE
    Ala J Med Sci; 1969 Jan; 6(1):75-84. PubMed ID: 5772903
    [No Abstract]   [Full Text] [Related]  

  • 44. Optical imaging of spiral waves: pharmacological modification of spiral-type excitations in a 2-dimensional layer of ventricular myocardium.
    Kodama I; Honjo H; Yamazaki M; Nakagawa H; Ishiguro Y; Okuno Y; Sakuma I; Kamiya K
    J Electrocardiol; 2005 Oct; 38(4 Suppl):126-30. PubMed ID: 16226087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiotoxicodynamics: Toxicity of Cardiovascular Xenobiotics.
    Menke NB; Walsh SJ; King AM
    Emerg Med Clin North Am; 2015 Aug; 33(3):563-95. PubMed ID: 26226867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The antiarrhythmic effect and possible ionic mechanisms of pilocarpine on animal models.
    Zhao WM; Qi HP; Liu Y; Chen W; Xie J; Pan ZY; Han HM; Chen LP; Li DL; Wang LY; Sun HL; Liu Y
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):242-7. PubMed ID: 19721134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response optimization of drug dosage: antiarrhythmic studies with tocainide.
    Meffin PJ; Winkle RA; Blaschke TF; Fitzgerald J; Harrison DC; Harapat SR; Bell PA
    Clin Pharmacol Ther; 1977 Jul; 22(1):42-57. PubMed ID: 872495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antiarrhythmic activity of lidocaine under conditions of lipid and carbohydrate metabolisms disturbances in modeling early occlusional and reperfusional arrhythmias].
    Artem'eva OV; Koriaĭ kina AV; Zor'kina AV
    Eksp Klin Farmakol; 2007; 70(1):22-5. PubMed ID: 17402587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical pharmacology of anti-arrhythymia agents. II. Lignocaine, mexiletine, tocainide, phenytoin].
    Witkowska M
    Kardiol Pol; 1981; 24(11-12):803-13. PubMed ID: 6804681
    [No Abstract]   [Full Text] [Related]  

  • 50. The cardioprotective and antiarrhythmic effects of Nardostachys chinensis in animal and cell experiments.
    Li M; Xu X; Yang X; Kwong JSW; Shang H
    BMC Complement Altern Med; 2017 Aug; 17(1):398. PubMed ID: 28797251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antifibrillatory effect of antiarrhythmic drugs of various classes under conditions of activation of the parasympathetic nervous system].
    Kaverina NV; Chichkanov GG; Tsorin IB
    Eksp Klin Farmakol; 2004; 67(6):30-1. PubMed ID: 15707011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of arginyl-vasopressin on various heart arrhythmias].
    Lychakov AV; Petrov AN; Shevchuk MK
    Biull Eksp Biol Med; 1999 Mar; 127(3):272-4. PubMed ID: 10225096
    [No Abstract]   [Full Text] [Related]  

  • 53. Novel quinolizidinyl derivatives as antiarrhythmic agents.
    Vazzana I; Budriesi R; Terranova E; Ioan P; Ugenti MP; Tasso B; Chiarini A; Sparatore F
    J Med Chem; 2007 Jan; 50(2):334-43. PubMed ID: 17228875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lidocaine as an anti-arrhythmia agent. The pharmacological, experimental and clinical background for its use].
    Flensted-Jensen E
    Ugeskr Laeger; 1969 Mar; 131(12):500-4. PubMed ID: 5793604
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of trimecaine derivatives and lidocaine on hemodynamics].
    Blinov DS; Kostin IaV; Volkova ND
    Eksp Klin Farmakol; 2004; 67(2):24-6. PubMed ID: 15188755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias(1).
    Members of the Sicilian Gambit
    Cardiovasc Res; 2001 Dec; 52(3):345-60. PubMed ID: 11738052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re: Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
    Madias JE
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E32; author reply E33. PubMed ID: 18298519
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparing the actions of the three flavone ingredients in choerospondias axillaris on arrhythmias induced by aconitine].
    Wang FH; Yang YM; Xu JH; Qin JM; Ying K; Zhang CZ; Song YT; Yu TF
    Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(14):1096-8. PubMed ID: 16161447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Is monomorphic arrhythmia monomorphic?].
    Moskalenko AV; El'kin IuE
    Biofizika; 2007; 52(2):339-43. PubMed ID: 17477064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Be careful in using flecainide by hemodialyzed patients].
    Montagnac R; Schoen E; Aliouche CP; Schillinger F
    Nephrol Ther; 2006 Dec; 2(7):442-5. PubMed ID: 17185235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.